Document is current
Any future updates will be listed below
-
Authors
Silwal, Ashok
House, Austin
Sandoval, Karin
Vijeth, Shaluah
Umbaugh, David
Crider, Albert
Mobayen, Shirin
Neumann, William
Witt, Ken A. https://orcid.org/0000-0002-8575-8552
-
Funding
Funding for this research was provided by:
National Institute on Aging (R01AG047858)
- License Information
-
More Information
Article History
Received: 1 June 2021
Revised: 10 September 2021
Accepted: 6 November 2021
First Online: 30 November 2021
Declarations
:
: Drs. Neumann, Sandoval, Crider, and Witt are co-inventors on patent applications for the development of SSTR4 agonists, through Southern Illinois University Edwardsville (USA Patent Application No. PCT/US2018/032368, European National Application No. 18798793.8, Japanese Application No. 2019-562574). Ken Witt is CEO of Somatolynk Inc., a company focused on advancement of SSTR4 agonists. No other declarations to declare.
